U.S., Nov. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07924605) titled 'PSMA PET/MRI for Predicting and Detecting Prostate Cancer' on Oct. 27.
Brief Summary: The goal of this clinical trial is to see if a drug called 18F-DCFPyL can help find prostate cancer or prostate cancer that has spread to other parts of the body. The main question it aims to answer is:
* Can 18F-DCFPyL predict response to therapy; and,
* Does 18F-DCFPyL improve detection of early signs of cancer.
Participants will undergo PET/MRI scans.
Study Start Date: Dec., 2026
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer
High-Risk Localized Prostate Cancer
Locally Advanced Prostate Cancer
Low-Risk Prostate Cancer
Intermediate ...